(Q37103157)

18 August 2017

1 reference

title

The use of botulinum neurotoxin type A (BoNTA) in urology (English)

1 reference

18 August 2017

A Apostolidis

1

1 reference

18 August 2017

C J Fowler

series ordinal

2

1 reference

18 August 2017

language of work or name

1 reference

6 March 2008

1 reference

Journal of Neural Transmission

18 August 2017

published in

1 reference

18 August 2017

volume

115

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

593-605

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-007-0862-x

18 August 2017

exact match

0 references

cites work

Intravesical capsaicin in patients with detrusor hyper-reflexia--a placebo-controlled cross-over study.

1 reference

12 December 2020

Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions

1 reference

12 December 2020

Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia

1 reference

12 December 2020

Treatment of overactive bladder with botulinum toxin type B: a pilot study

1 reference

12 December 2020

P2X3 knock-out mice reveal a major sensory role for urothelially released ATP

1 reference

12 December 2020

Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1

1 reference

12 December 2020

Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study

1 reference

12 December 2020

Purine-mediated signalling in pain and visceral perception

1 reference

12 December 2020

Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study

1 reference

12 December 2020

Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics

1 reference

12 December 2020

Overactive bladder: a better understanding of pathophysiology, diagnosis and management

1 reference

12 December 2020

Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study.

1 reference

12 December 2020

Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins

1 reference

12 December 2020

Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins

1 reference

12 December 2020

Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction.

1 reference

12 December 2020

Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland

1 reference

12 December 2020

Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury

1 reference

12 December 2020

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

12 December 2020

Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging

1 reference

12 December 2020

Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience

1 reference

12 December 2020

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice

1 reference

12 December 2020

Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.

1 reference

12 December 2020

Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin?

1 reference

12 December 2020

P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin.

1 reference

12 December 2020

Botox-induced prostatic involution

1 reference

12 December 2020

Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study

1 reference

12 December 2020

Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis

1 reference

12 December 2020

Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation

1 reference

12 December 2020

Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes.

1 reference

12 December 2020

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

1 reference

12 December 2020

Influence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro

1 reference

12 December 2020

Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results

1 reference

12 December 2020

A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity.

1 reference

12 December 2020

Augmentation cystoplasty

1 reference

12 December 2020

The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor.

1 reference

12 December 2020

Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra

1 reference

12 December 2020

Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results

1 reference

12 December 2020

European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity

1 reference

12 December 2020

Effects of Botulinum a Toxin on Detrusor-Sphincter Dyssynergia in Spinal Cord Injury Patients

1 reference

12 December 2020

Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents

1 reference

12 December 2020

Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder

1 reference

12 December 2020

Botulinum toxin in the treatment of chronic urinary retention in women

1 reference

12 December 2020

Effectiveness of urethral injection of botulinum A toxin in the treatment of voiding dysfunction after radical hysterectomy.

1 reference

12 December 2020

Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.

1 reference

12 December 2020

Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder

1 reference

12 December 2020

Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity

1 reference

12 December 2020

Adverse events after botulinum A toxin injection for neurogenic voiding disorders

1 reference

12 December 2020

ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes--a possible sensory mechanism?

1 reference

12 December 2020

Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder

1 reference

12 December 2020

Interstitial cystitis in the UK: results of a questionnaire survey of members of the Interstitial Cystitis Support Group

1 reference

12 December 2020

Electrical characteristics of suburothelial cells isolated from the human bladder

1 reference

12 December 2020

Bladder Adelta afferent nerve activity in normal cats and cats with feline interstitial cystitis

1 reference

12 December 2020

Inhibitory actions of calcitonin gene-related peptide and capsaicin: evidence for local axonal reflexes in the bladder wall

1 reference

12 December 2020

What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity?

1 reference

12 December 2020

Increased number of substance P positive nerve fibres in interstitial cystitis

1 reference

12 December 2020

Botulinum toxin a has antinociceptive effects in treating interstitial cystitis.

1 reference

12 December 2020

Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs

1 reference

12 December 2020

Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity.

1 reference

12 December 2020

Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity

1 reference

12 December 2020

Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?

1 reference

12 December 2020

Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.

1 reference

12 December 2020

P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis

1 reference

12 December 2020

Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladder

1 reference

12 December 2020

Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment

1 reference

12 December 2020

Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions

1 reference

12 December 2020

Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence

1 reference

12 December 2020

Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease.

1 reference

12 December 2020

Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates

1 reference

12 December 2020

Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia

1 reference

12 December 2020

Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial

1 reference

12 December 2020

Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis

1 reference

12 December 2020

Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells.

1 reference

12 December 2020

Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia

1 reference

12 December 2020

Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder

1 reference

12 December 2020

Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients

1 reference

12 December 2020

Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?

1 reference

12 December 2020

Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis

1 reference

12 December 2020

Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report

1 reference

12 December 2020

Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients

1 reference

12 December 2020

Immunohistochemical evidence of vanilloid receptor 1 in normal human urinary bladder

1 reference

12 December 2020

Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats

1 reference

12 December 2020

Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A.

1 reference

12 December 2020

Cost-Consequence Analysis Evaluating the Use of Botulinum Neurotoxin-A in Patients with Detrusor Overactivity Based on Clinical Outcomes Observed at a Single UK Centre

1 reference

12 December 2020

The role of the human bladder lamina propria myofibroblast

1 reference

12 December 2020

A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.

1 reference

12 December 2020

Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics

1 reference

12 December 2020

Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity.

1 reference

12 December 2020

Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity

1 reference

12 December 2020

[Epidemiology and etiology of overactive bladder]

1 reference

12 December 2020

Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial

1 reference

12 December 2020

Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system

1 reference

12 December 2020

Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.

1 reference

12 December 2020

Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder

1 reference

12 December 2020

Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin.

1 reference

12 December 2020

Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study

1 reference

12 December 2020

Botulinum A toxin as a treatment of detrusor-sphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injections

1 reference

12 December 2020

Histologic features in the urinary bladder wall affected from neurogenic overactivity--a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A

1 reference

12 December 2020

Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis

1 reference

12 December 2020

Localization of M 2 and M 3 Muscarinic Receptors in Human Bladder Disorders and Their Clinical Correlations

1 reference

12 December 2020

Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity.

1 reference

12 December 2020

10.1007/S00702-007-0862-X

Identifiers

DOI

1 reference

18 August 2017

1 reference